Article Details

Chinese cancer drug developer Biostar closes $135m pre-IPO round

Retrieved on: 2020-11-26 05:15:00

Tags for this article:

Click the tags to see associated articles and topics

Chinese cancer drug developer Biostar closes $135m pre-IPO round. View article details on HISWAI: https://www.dealstreetasia.com/stories/biostar-135m-pre-ipo-217301/

Excerpt

... firm's pre-IPO round, was jointly led by biomedicine-focused investment firm Efung Capital and <b>Matrix Partners</b> China, said the firm in a statement.

Article found on: www.dealstreetasia.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up